Alternating-Day Cyclosporine and Prednisone for Treatment of High-Risk Chronic Graft-v-Host Disease

Therapy of chronic graft-v-host disease (GVHD) has been unsatisfactory in patients with platelet counts

Saved in:
Bibliographic Details
Published in:Blood 1988-08, Vol.72 (2), p.555-561
Main Authors: Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P., Anasetti, C., Loughran, T.P., Hill, R., Shields, A., Yee, G., Shulman, H., Nims, J., Strom, S., Thomas, E.D.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Biological and medical sciences
Bone Marrow Transplantation
Child
Child, Preschool
Chronic Disease
Cyclosporins - administration & dosage
Cyclosporins - adverse effects
Cyclosporins - blood
Drug Administration Schedule
Drug Therapy, Combination
Female
Graft vs Host Disease - drug therapy
Graft vs Host Disease - mortality
Humans
Immunomodulators
Infant
Infections - etiology
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Prednisone - administration & dosage
Prednisone - adverse effects
Thrombocytopenia - etiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Therapy of chronic graft-v-host disease (GVHD) has been unsatisfactory in patients with platelet counts
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V72.2.555.555